Bayern Kapital and HTGF seed Mecuris

Mecuris, a spinout of Ludwig-Maximilian University Hospital, received a “high six-figure sum” in seed financing from the two state-backed groups.

Germany-based orthopaedic technology developer Mecuris, a spinout of Ludwig-Maximilian University (LMU) Hospital in Munich, has secured a “high six-figure sum” in seed financing from Bavarian state-owned investment firm Bayern Kapital.

High Tech Gründerfonds (HTGF), an early-stage investment group instituted by the German government, also invested in the round.

Founded in 2016, Mecuris is the developer of a platform that allows medical technicians to use data from patients’ three-dimensional scans to create orthopaedic aids and artificial limbs that are designed to fit each individual. 

Mecuris makes the aids and limbs with the help of three-dimensional printers, and delivers them to their customers.

Wolf-Peter Werner, chief financial officer of Mecuris, said: “Our platform is a self-learning system that uses processes from the fields of artificial intelligence and medical image processing. The production of orthopaedic aids is thus conducted in a decentralised manner using [three-dimensional printing] in certified centres.”

Frank Hensel, investment manager at HTGF, added: “Doctors and orthopaedic technicians are able to use Mecuris’ technology without needing to have any previous technical know-how in [computer-aided design] or three-dimensional printing. Production time is reduced significantly thanks to the digital process chain.”

- Image of a prosthetic leg courtesy of Mecuris.


Supporting articles

Copyright Mawsonia Limited 2010. Please don't cut articles from or the PDF and redistribute by email or post to the web without written permission.